Related Experiment Videos
Clinical immunology in practice, new opportunities
1Allergy Associates of the Palm Beaches, North Palm Beach, FL 33408, USA. latallergy@aol.com
Clinical Reviews in Allergy & Immunology
|December 4, 2004
Summary
Advances in allergy and immunology offer new diagnostic and treatment options, but clinical implementation faces hurdles. Innovations like intravenous immunoglobulin (IVIG) and omalizumab improve patient care despite managed care challenges.
Area of Science:
- Allergy and Immunology
- Clinical Practice
- Healthcare Management
Background:
- Research offers new diagnostic and treatment opportunities for allergic and immunological disorders.
- Clinical application of these advances is hindered by practical challenges.
- Managed care significantly impacts medical decisions, causing frustration for patients and physicians.
Purpose of the Study:
- To highlight the challenges in implementing new diagnostic and treatment advances in clinical practice.
- To identify new opportunities for improved diagnosis and treatment in immunological diseases.
- To discuss the benefits of specific advancements like IVIG and omalizumab.
Main Methods:
- Review of current challenges in accessing new immunological tests.
- Analysis of the impact of managed care on clinical decision-making.
- Discussion of emerging treatment options and their clinical utility.
Main Results:
- New tests face insurance and laboratory access issues, potentially leading to delays and inaccurate results.
- Managed care creates barriers to timely and appropriate patient care.
- Enhanced decision-making capabilities and new therapies like IVIG and omalizumab offer significant patient benefits.
Conclusions:
- Despite implementation challenges, advancements in immunological treatments are improving patient outcomes.
- Strategic use of therapies like IVIG and omalizumab enhances safety and efficacy.
- Tertiary care centers may offer more accessible laboratory services for complex immunological conditions.